Review of CHAARTED Trial Results
CTA Advisory Board member, Neal Shore, MD, puts CHAARTED trial results into context.
All articles by Neal Shore, MD, FACS
ChemotherapyAdvisor.com Editorial Board Recommends High-Impact Abstracts from the 2013 Genitourinary Cancers Symposium
Dr. Neal Shore, MD, FACS, of Atlantic Urology Clinics shares his list of recommended abstracts that will be presented at the 2013 Genitourinary Cancers Symposium.
Active Surveillance for Low-Risk Prostate Cancer May Improve Quality of Life
In this article, Advisory Board member Neal Shore, MD, FACS, discusses barriers to clinicians recommending active surveillance for men with low-risk prostate cancer.
Case Study: Castrate-Resistant Prostate Cancer
Although there are new therapies for M1CRPC patients and others pending, ideal sequencing regimen is still not certain.
- Loading...
Loading...
Next post in From The Advisory Board
Loading... 
Loading...